AUGA group, AB interim financial results for the 3-month period ended 31 March 2024
GlobeNewswire
In the first quarter of 2024, AUGA group, AB and its subsidiaries (hereinafter – the Group) had sales revenue of EUR 19.74..
In the first quarter of 2024, AUGA group, AB and its subsidiaries (hereinafter – the Group) had sales revenue of EUR 19.74..
· TLX591 is an investigational anti-PSMA^1 radio-antibody-drug conjugate (rADC) therapy being developed for the treatment of..
EQS Newswire / 30/05/2024 / 09:30 CET/CESTBANGKOK THAILAND - Media OutReach Newswire - 30 May 2024 -* *Leading education group..